Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility.
Henry-Blake C, Balachandrakumar V, Kassab M, Devonport J, Matthews C, Fox J, Baggus E, Henney A, Stern N, Cuthbertson DJ, Palmer D, Johnson PJ, Hughes DM, Hydes TJ, Cross TJS.
Henry-Blake C, et al.
J Gastroenterol Hepatol. 2024 Dec;39(12):2817-2825. doi: 10.1111/jgh.16727. Epub 2024 Aug 27.
J Gastroenterol Hepatol. 2024.
PMID: 39191435
Free PMC article.